Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ershiwuwei Songshi Wan is a traditional Tibetan medicine formulated as an oral pill, primarily indicated for the treatment of liver and gallbladder disorders. Developed and manufactured by Xizang Ganlu Tibetan Medicine, the formulation consists of 25 natural ingredients, including turquoise, pearl, coral, saffron, and various herbal extracts. In the context of Tibetan medicine, it is used to clear 'liver heat,' detoxify the liver, and promote gallbladder health. Clinical applications include the treatment of chronic hepatitis, liver cirrhosis, jaundice, and cholecystitis. The product is officially approved by the National Medical Products Administration (NMPA) of China with National Drug License Numbers Z54020082 and Z54020061.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ershiwuwei Songshi Wan.